ClinicalTrials.Veeva

Menu

Letrozole Pretreatment With Misoprostol Induction of Abortion In First-Trimester Missed Miscarriage

Cairo University (CU) logo

Cairo University (CU)

Status and phase

Unknown
Phase 4

Conditions

Missed Abortion

Treatments

Drug: placebo then misoprostol
Drug: letrozole then misoprostol

Study type

Interventional

Funder types

Other

Identifiers

NCT04215835
letrozole pretreatment

Details and patient eligibility

About

This study compares the success rate of letrozole and misoprostol versus misoprostol alone for medical termination of first-trimester pregnancy among women with one or more previous cesarean deliveries.

Enrollment

200 estimated patients

Sex

Female

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Gestational age less than 64 days gestation (<9 wks).
  • Hemoglobin >10 g/dL.
  • BMI between 18.5 kg/m2 and 25 kg/m2.
  • Missed abortion.
  • previous one or more cesarean delivaries

Exclusion criteria

  • Molar pregnancy.
  • Fibroid uterus.
  • Uterine anomalies.
  • Coagulopathy.
  • Medical disorder that contraindicate induction of abortion (e.g. heart failure).
  • Previous attempts for induction of abortion in the current pregnancy.
  • Allergy to misoprostol or letrozole.

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Quadruple Blind

200 participants in 2 patient groups, including a placebo group

study group
Experimental group
Description:
3 tablets of Letrozole 2.5 mg will be given as single daily dose, 7.5 mg per day for two days at home and the third dose will be given on admission to hospital on day 3 and will be followed by vaginal misoprostol 800 mcg every three hours up to maximum two doses.
Treatment:
Drug: letrozole then misoprostol
control group
Placebo Comparator group
Description:
three tablets of placebo will be given as a single daily dose, for two days at home and will be admitted on day 3 and continue treatment with misoprostol 800 mcg every three hours up to maximum two doses
Treatment:
Drug: placebo then misoprostol

Trial contacts and locations

0

Loading...

Central trial contact

AHMED SAMY

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems